Autopsy report · NCT04896827

DNIC Using Deep Learning and Artificial Intelligence

“The funding of the study is challenged. We might resume enrollment if new funds are found or will terminate the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Suspended: paused, and may or may not restart.
• 244 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Université de Sherbrooke

Sponsor type

University, hospital or other

Conditions

Chronic Pain

Interventions

Conditioned pain modulation test

Participants

244 (planned, not actual)

Sites

1

Countries

Canada

Trials that died the same way

• Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet
  “Loss of funding- Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.” (75% match in meaning)
• Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
  “The study was terminated because of significant enrollment challenges” (75% match in meaning)
• Pharmacogenetic Testing for Medication Management.
  “Loss of funding for the continuation of the Study” (75% match in meaning)
• Tracking Biomarkers of Speech Intelligibility
  “Funding for this study ended prior to enrollment of any participants due to a change in funding.” (75% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.